MYMD-1, a novel alkaloid compound, ameliorates the course of experimental autoimmune encephalomyelitis

Justin D. Glenn, Itzy Morales Pantoja, Patrizio Caturegli, Katharine A. Whartenby

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'MYMD-1, a novel alkaloid compound, ameliorates the course of experimental autoimmune encephalomyelitis'. Together they form a unique fingerprint.

Medicine & Life Sciences